I just want to echo that I think it's very hard to exactly predict right now when this vaccine will be available. As you can imagine, we have people here who are working essentially around the clock to get this done as quickly as possible. I think what we might see, though—and this is what I want to alert the committee to—is that some of these vaccine candidates, our own or others from around the globe, might get approval under what is called an emergency authorization. Essentially, after completion of a phase II trial in humans, it may get approval from the regulators to be used in individuals who are facing a higher risk of being infected, for example. Under that scenario, I could see that under an emergency authorization, the first vaccines might become available within the next 12 months.
On April 30th, 2020. See this statement in context.